Hi,

Ghana's Parliament legalized hemp cultivation for industrial and medicinal purposes, marking another stride in global cannabis policy changes. Meanwhile, the US Congress is weighing its passion for war against its dislike for cannabis as it debates loosening cannabis restrictions for military recruits to stem a recruit shortage. Ironically, as this softening occurs, the Republican House chose to celebrate the 10th anniversary of the SAFE Banking Act by rejecting a common-sense GOP proposal. It was to analyze state cannabis laws, a critical step prior to federal legalization. Federal legalization will come. And I'm pretty sure when it does, politicians will mess it up. ;)

Feel free to subscribe to our Cannabis or CBD News Roundups.

Thanks and I hope you have a terrific week!
Jessica

07/10/23
Chicago Atlantic pledges up to $150M to New York's social equity fund for cannabis dispensaries. The investment deal aims to support small businesses through loans.
The SEC orders Sol Global founder Andy DeFrancesco to pay millions in a stock fraud case. He was involved in a scheme of false statements and a pump-and-dump of Cool Holdings' stock.
Arkansas and Connecticut continue breaking marijuana sales records in June, while Michigan sees market prices stabilize after hitting record lows.
Illinois experiences a turnaround in cannabis sales, with June recording the highest monthly sales of the year so far. Sales increased by 8% year-over-year, overcoming several months of sluggish performance.
Colorado's marijuana sales in April 2023 reach their lowest point since 2018, with $131M compared to over $153M in April 2022.
Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) unveils a strategic national rebrand of its Select cannabis lifestyle brand across 15 U.S. states.
InterCure Ltd. (Nasdaq: INCR) (TSX: INCR.U) (TASE: INCR), also known as Canndoc, decides to voluntarily delist its common shares from the Toronto Stock Exchange, citing limited benefits.

07/11/23
Maryland grants a $40M fund to a few social equity marijuana companies, aiming to facilitate their entry into the recreational cannabis market.
InterCure Ltd (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) plans to delist its common shares from the Toronto Stock Exchange, determining that maintaining the listing does not provide significant benefits.
SpringBig Holdings Inc. (Nasdaq: SBIG) forecasts a path to profitability following notable growth in the second quarter. The Florida-based cannabis software solutions provider updates its outlook for the second half of the fiscal year.
Detroit will accept applications for the second round of limited marijuana business licenses, including dispensaries and consumption lounges, starting August 1.
The Alabama Medical Cannabis Commission reschedules the awarding of business licenses for August 10, replacing the previously announced selections.

07/12/23
David Ferraro receives a final judgment from the U.S. Securities and Exchange Commission for his alleged involvement in microcap stock promotion schemes, resulting in over $140,000 in profits.
Massachusetts dispensaries generate $151.8M in marijuana sales, comprising $132.8M in recreational sales and $19M in medical sales for the month.
IGC Pharma Inc (NYSE: IGC) releases its fiscal-year 2023 financial results, highlighting strategic moves to advance Alzheimer's disease treatment.
Opening marijuana shops in Illinois poses challenges for the upcoming 55 social equity license lottery winners, following previous difficulties in launching cannabis businesses.
The Ohio State Medical Board of Ohio adds irritable bowel syndrome as a qualifying condition for medical marijuana but rejects autism spectrum disorder and obsessive-compulsive disorder.

07/13/23
Alberta -based 420 Investments Ltd. merges with Toronto-based Trees Corp. (NEO: TREE) in a reverse takeover, pending Cboe Canada's approval.
Grown Rogue International Inc. (CSE: GRIN) (OTC: GRUSF) closes the first tranche of a $5M non-brokered private placement of convertible debentures.
BZAM Ltd. (CSE: BZAM) (US-OTC:BZAMF) acquires additional class A shares of BZAM Cannabis Corp., increasing its ownership stake to 71.2%.
Botanica secures $9M in Series B funding led by KEY Investment Partners and GreenAxs Capital, with participation from other prominent firms.